{"version":"1.0","provider_name":"Trade Brains Features","provider_url":"https:\/\/tradebrains.in\/features","author_name":"PTI News","author_url":"https:\/\/tradebrains.in\/features\/author\/ptinews\/","title":"MSN Laboratories receives tentative approval for generic version of Cangrelor","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"qZWVlxng0G\"><a href=\"https:\/\/tradebrains.in\/features\/biz-msn-lab\/\">MSN Laboratories receives tentative approval for generic version of Cangrelor<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/tradebrains.in\/features\/biz-msn-lab\/embed\/#?secret=qZWVlxng0G\" width=\"600\" height=\"338\" title=\"&#8220;MSN Laboratories receives tentative approval for generic version of Cangrelor&#8221; &#8212; Trade Brains Features\" data-secret=\"qZWVlxng0G\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"New Delhi, Dec 16 (PTI) Drug firm MSN Laboratories on Thursday said it has received tentative approval for its generic version of Cangrelor, used in patients undergoing coronary angioplasty to reduce risk of blood clots and heart attack, from the US health regulator. The approval by the US Food and Drug Administration (USFDA) comes close [&hellip;]"}